TY  - GEN 
AU  - Mosquera Orgueira, Adrián
AU  - Peleteiro Raindo, Andrés
AU  - Cid López, Miguel
AU  - Antelo Rodríguez, Beatriz
AU  - Díaz Arias, José
AU  - Ferreiro Ferro, Roi
AU  - Alonso Vence, Natalia
AU  - Bendaña López, Mª Ángeles
AU  - Abuin Blanco, Aitor
AU  - Bao Pérez, Laura
AU  - Melero Valentín, Paula
AU  - González Pérez, Marta Sonia
AU  - Cerchione, C.
AU  - Martinelli, G.
AU  - Montesinos Fernández, P.
AU  - Pérez Encinas, Manuel Mateo
AU  - Bello López, José Luis
PY  - 2021
SN  - 1932-6203
UR  - http://hdl.handle.net/20.500.11940/20388
AB  - BACKGROUND: FLT3 mutation is present in 25-30% of all acute myeloid leukemias (AML), and it is associated with adverse outcome. FLT3 inhibitors have shown improved survival results in AML both as upfront treatment and in relapsed/refractory disease....
LA  - eng
KW  - Biomarkers
KW  - DNA (Cytosine-5-)-Methyltransferases
KW  - DNA Methyltransferase 3A
KW  - Gene Expression Profiling
KW  - Humans
KW  - Leukemia
KW  - Leukemia, Myeloid, Acute
KW  - Mutation
KW  - Nuclear Proteins
KW  - Nucleophosmin
KW  - Staurosporine
KW  - fms-Like Tyrosine Kinase 3
TI  - Gene expression profiling identifies FLT3 mutation-like cases in wild-type FLT3 acute myeloid leukemia
DO  - 10.1371/JOURNAL.PONE.0247093
KW  - AS Santiago AP
KW  - CHUS
KW  - IDIS
KW  - AS Lugo AP
KW  - HULA
VL  - 16
ER  -